Study guide
Serotonin toxicity and bipolar presentations
AMC CAT MCQ Examination AMC Part 1
Track your progress as you read
Finished sections get a check mark.
1 Acute Coronary Syndromes & ECG Localization
ACS recognition and ECG localisation Reperfusion and infarction complications
2 Heart Failure, Cardiogenic Shock & Cardiac Arrhythmias
Heart failure assessment and treatment Arrhythmias and conduction emergencies
3 Systemic Hypertension & Peripheral Vascular Disease
Blood pressure and cardiovascular risk Secondary hypertension and arterial disease
4 Valvular Heart Disease, Infective Endocarditis & Pericarditis
Aortic and mitral valve disease Endocarditis and pericardial emergencies
5 Asthma & COPD Acute Flares and Maintenance
Asthma and COPD diagnosis and maintenance Acute asthma and COPD exacerbations
6 Pneumonia, pleural disease and respiratory failure
Pneumonia and infected pleural collections Pulmonary embolism, effusions and pneumothorax Respiratory failure, ARDS and sepsis
7 GI bleeding, bowel inflammation and malabsorption
GI bleeding assessment and resuscitation Varices, ulcers, reflux and lower GI bleeding IBD patterns and severe colitis assessment IBD treatment, coeliac disease and IBS
8 Chronic Liver Disease, Cirrhosis Complications & Acute Hepatitis
Cirrhosis diagnosis and prognosis Decompensation, viral hepatitis and surveillance
9 Diabetes, thyroid and adrenal disease
Diabetes diagnosis and ongoing care DKA, HHS and complication monitoring Thyroid disease assessment Thyroid emergencies and adrenal disease
10 Acute Kidney Injury, Chronic Kidney Disease & Fluid/Electrolyte Emergencies
AKI and chronic kidney disease Potassium and sodium emergencies
11 Anaemias, Inflammatory Arthropathies & Geriatric Comprehensive Assessment
Anaemia, bruising and blood disorders Arthritis, autoimmune disease and geriatric care
12 Evaluation of the Acute Abdomen, Peritonitis & Appendicitis
Abdominal pain, peritonitis and resuscitation Appendicitis diagnosis and treatment Perforation and mesenteric ischaemia
13 Small and Large Bowel Obstruction & Colorectal Surgical Pathology
Small bowel obstruction Colonic obstruction, volvulus and cancer recognition Colorectal care, diverticulitis and anorectal symptoms
14 Gallbladder Disease, Biliary Tract Infections & Acute Pancreatitis
Gallstones and biliary obstruction Cholangitis and pancreatitis diagnosis Pancreatitis severity and treatment
15 Advanced Trauma Life Support, Primary Survey & Life-Threatening Thoracic Injuries
Trauma primary survey and adjuncts Chest trauma and immediate threats
16 Traumatic Brain Injury, Intracranial Haemorrhage & Spinal Cord Clearance
Head injury, imaging and haemorrhage Herniation and spinal cord injury
17 Major Fractures, Joint Dislocations & Acute Compartment Syndrome
Fracture assessment and open injuries Compartment syndrome, dislocations and pelvic injury
18 Thermal Burns, Haemorrhagic Shock Resuscitation & Surgical Wound Care
Burn assessment and fluid resuscitation Bleeding shock, wound care and tetanus
19 Aortic Aneurysms & Acute Arterial Limb Ischaemia
Aneurysm recognition and planned care Ruptured aneurysm and acute limb ischaemia
20 Urological Emergencies, Testicular Torsion & Haematuria Investigation
Retention, stones and obstructed infection Scrotal pain and haematuria
21 Preoperative Risk Stratification & Postoperative Surgical Complications
Preoperative assessment and medicines Postoperative complications and prevention
22 Early Pregnancy Bleeding, Ectopic Pregnancy & Antenatal Screening
Miscarriage and ectopic pregnancy Antenatal screening and early-pregnancy comparisons
23 Hypertensive Disorders of Pregnancy & Medical Complications in Pregnancy
Pregnancy hypertension and preeclampsia Eclampsia, HELLP and antepartum bleeding
24 Intrapartum Monitoring, Postpartum Haemorrhage & Obstetric Emergencies
Labour physiology and CTG assessment CTG response and postpartum haemorrhage Obstetric emergencies and preterm birth
25 Abnormal Uterine Bleeding, Pelvic Pain & Endometriosis
Abnormal bleeding and structural causes Endometrial sampling and endometriosis PCOS diagnosis and long-term care
26 Contraception, Emergency Contraception & Pregnancy Termination
Contraceptive choice and missed pills Emergency contraception and abortion
27 Australian Cervical Screening Program & Gynaecological Malignancies
Cervical screening and cervical cancer Endometrial and ovarian cancer
28 Neonatal Resuscitation, Congenital Conditions & Neonatal Jaundice
Newborn resuscitation, Apgar and cyanosis Neonatal jaundice assessment Jaundice treatment and congenital screening
29 Developmental Milestones, Growth Charts & Failure to Thrive
Developmental milestones Regression, autism and support Faltering growth and developmental comparisons
30 The Limping Child, Septic Arthritis vs Transient Synovitis & Paediatric Hip Conditions
Limp assessment and septic-joint risk Joint-infection management and Perthes disease SUFE and paediatric hip comparisons
31 Croup, Bronchiolitis, Paediatric Asthma & Anaphylaxis
Croup Bronchiolitis Paediatric asthma Paediatric anaphylaxis
32 Evaluation of the Febrile Child, Sepsis & Meningococcal Disease
Febrile neonates and young infants Meningococcal disease and paediatric sepsis Bacterial meningitis and CSF interpretation Kawasaki disease and follow-up
33 Paediatric Surgical Abdomen, Dehydration & Child Protection / Non-Accidental Injury
Pyloric stenosis Intussusception and dehydration Child protection and injury assessment
34 The Mental State Examination & Suicide Risk Stratification
Mental state examination and psychotic symptoms Suicide formulation and mental health law
35 Major Depressive Disorder, Bipolar Affective Disorder & Mood Stabilisers
Depression assessment and treatment Serotonin toxicity and bipolar presentations Mood stabilisers and ECT
36 Generalised Anxiety, Panic Disorder, PTSD & Obsessive-Compulsive Disorder
Anxiety, panic and agoraphobia OCD and trauma-related disorders
37 Schizophrenia, Acute Psychosis & Antipsychotic Management
Psychosis assessment and antipsychotics Clozapine and severe adverse effects
38 Substance Use Disorders & Acute Withdrawal Syndromes
Substance disorders and alcohol withdrawal Wernicke disease, opioids and stimulants
39 Delirium vs Dementia, Perinatal Mood Disorders & Paediatric Psychiatry
Delirium and dementia assessment Cognitive behaviour, perinatal and childhood psychiatry
40 Medicare, PBS, AHPRA & Good Medical Practice Framework
Australian health services and Medicare PBS access and professional registration Professional boundaries and notifications
41 Informed Consent (Rogers v Whitaker), Mental Capacity & Involuntary Treatment
Consent, material risks and young people Capacity, refusal and substitute decisions
42 Patient Privacy, Confidentiality Exceptions & Mandatory Notifications
Privacy, disclosure and child reporting Driving fitness and threat disclosure
43 First Nations health and preventive care
First Nations health, determinants and cultural safety Community care, Item 715 and CTG medicines Immunisation and cancer screening entry points Screening pathways and primary CVD prevention
44 Epidemiological Metrics, Clinical Study Designs & Notifiable Communicable Diseases
Epidemiology, calculations, bias and surveillance
45 Neurological presentations
Stroke, TIA and focal weakness Headache, facial pain and vertigo Seizures, collapse and altered consciousness Numbness, movement disorders and generalised weakness
46 Musculoskeletal pain
Back, neck, bone and soft tissue pain
47 Eye presentations
Altered vision and retinal disease Red eye, ocular injury and discharge
48 Ear, nose, throat and oral health
Ear pain, hearing loss and tinnitus Nasal problems, neck lumps, hoarseness and dysphagia Toothache, mouth symptoms, dry mouth and halitosis
49 Skin, hair and nails
Rash, itch, infection and skin ulcers Skin lesions, hair loss and nail abnormalities
50 Breast health and feeding
Breast lumps, discharge and breastfeeding problems
51 Sexual and reproductive presentations
Genital symptoms, discharge and pelvic infection Menopause, prolapse and urinary symptoms Infertility and sexual dysfunction
52 Palliative care and carers
The dying patient, symptoms and carers
53 Eating disorders and personality care
Eating disorders, obesity and weight change Personality difficulties, self-harm and complex care
54 Sleep presentations
Insomnia, snoring and daytime sleepiness
55 Poisoning, resuscitation and environmental emergencies
Poisoning, toxidromes and antidote decisions Cardiopulmonary arrest, choking and emergency help Bites, stings, heat, cold and drowning
56 Communication, rights and professional practice
Communication, handover, errors and complaints Healthcare rights, inclusive care and equitable access Certificates, deaths, CPD and supervision Telehealth, images, prescribing and doctors' health
57 Genetics, research and donation
Genetic testing, research and organ donation
58 Travel, fever and outbreaks
Fever, travellers and outbreak response
Serotonin toxicity and bipolar presentations
Key Takeaways Explain This Topic AI
Clonus and hyperreflexia support serotonin toxicity.
Stop implicated serotonergic medicines and provide urgent supportive treatment when toxicity is suspected.
Antidepressant monotherapy can be inappropriate in bipolar illness.
Last updated: October 2026
Serotonin Syndrome (Serotonin Toxicity)
Serotonin toxicity can follow a serotonergic overdose, dose change or interacting drugs. Multiple agents raise risk, but a single agent can cause toxicity.
High-Risk Drug Combinations
SSRI / SNRI + Monoamine Oxidase Inhibitors (MAOIs: phenelzine, tranylcypromine, moclobemide).
SSRI / SNRI + Synthetic Opioids with serotonin reuptake inhibition ( tramadol , pethidine, fentanyl, methadone, dextromethorphan).
SSRI / SNRI + Herbal / Illicit Serotonergics ( St John's Wort , MDMA / ecstasy, amphetamines, cocaine).
SSRI / SNRI + Antibiotics with MAOI activity ( linezolid ).
Washout Rules : Switching from an SSRI to an irreversible MAOI requires a 2-week washout (except fluoxetine , which requires a 5-week washout due to the long half-life of its active metabolite norfluoxetine).
Clinical Presentation & Hunter Criteria
Serotonin syndrome manifests with a rapid onset (often within 6 to 24 hours of drug exposure or dose escalation) characterized by a clinical triad:
Neuromuscular Excitation : Spontaneous, inducible, or ocular clonus; hyperreflexia (pronounced in lower limbs); tremor; myoclonus; and hypertonia.
Autonomic Instability : Diaphoresis, hyperthermia ( > 38.5 ∘ C > 38.5^\circ\text{C} > 38. 5 ∘ C in severe cases), tachycardia, labile blood pressure, flushing, and diarrhoea.
Altered Mental State : Agitation, delirium, confusion, restlessness, and hypervigilance.
Differential Diagnosis: Serotonin Syndrome vs NMS
Precipitating Drugs : Serotonin Syndrome: Serotonergic agents (SSRIs, SNRIs, MAOIs, tramadol); Neuroleptic Malignant Syndrome (NMS): Dopamine antagonists (antipsychotics, metoclopramide)
Onset Velocity : Serotonin Syndrome: Rapid (hours to 24 hours post-dose); Neuroleptic Malignant Syndrome (NMS): Gradual (develops over days to 2 weeks)
Neuromuscular Tone : Serotonin Syndrome: Hyperreflexia, clonus (ocular/inducible), tremor; Neuroleptic Malignant Syndrome (NMS): "Lead-pipe" rigidity , hyporeflexia, bradykinesia
Pupils : Serotonin Syndrome: Dilated (mydriasis); Neuroleptic Malignant Syndrome (NMS): Normal
Gastrointestinal : Serotonin Syndrome: Hyperactive bowel sounds, diarrhoea; Neuroleptic Malignant Syndrome (NMS): Normal or decreased bowel sounds
Specific Antidote : Serotonin Syndrome: Cyproheptadine (5-HT2A antagonist); Neuroleptic Malignant Syndrome (NMS): Bromocriptine (dopamine agonist) / Dantrolene
Emergency Management
Immediate Cessation : Discontinue all serotonergic medications.
Supportive Care : Intravenous fluid resuscitation with 0.9 % 0.9\% 0.9% sodium chloride; active external cooling (cooling blankets, ice packs; avoid antipyretics like paracetamol as fever is driven by muscular rigidity, not hypothalamic set-point reset).
Sedation & Muscle Relaxation : Intravenous benzodiazepines (e.g., diazepam 5 to 10 mg 5\text{ to }10\text{ mg} 5 to 10 mg IV every 10–15 minutes) to alleviate agitation, dampen hyperadrenergic drive, and control muscular hyperactivity.
Specialist treatment: Supportive care, benzodiazepines, temperature control and organ support are primary. Cyproheptadine may be considered in selected cases after toxicology advice; evidence is limited, and it is not a definitive antidote that replaces resuscitation.
Intensive Care & Neuromuscular Blockade : If core temperature exceeds 39.5 ∘ C 39.5^\circ\text{C} 39. 5 ∘ C or severe rigidity threatens rhabdomyolysis and metabolic acidosis, emergency endotracheal intubation, mechanical ventilation, and non-depolarizing neuromuscular paralysis (vecuronium) are lifesaving.
Bipolar Affective Disorder
Bipolar disorder is characterized by pathological oscillations between depressive episodes and states of abnormally elevated, irritable, or energized mood.
Diagnostic Distinction: Bipolar I vs Bipolar II
Bipolar I Disorder : Mandates the occurrence of at least one lifetime manic episode . A depressive episode is typical but not strictly required for formal diagnosis.
Manic Episode : An abnormally and persistently elevated, expansive, or irritable mood, accompanied by persistently increased goal-directed activity or energy, lasting at least 7 consecutive days (or any duration if psychiatric hospitalization is required ).
Symptoms (must have ≥ 3 \ge 3 ≥ 3 , or ≥ 4 \ge 4 ≥ 4 if mood is only irritable): Grandiosity/inflated self-esteem, decreased need for sleep (feels fully rested after 2–3 hours), pressured speech, flight of ideas/racing thoughts, extreme distractibility, increased goal-directed activity or psychomotor agitation, and excessive involvement in high-risk pleasurable activities (spending sprees, sexual indiscretions, reckless driving).
Severity : Causes marked impairment in social or occupational functioning, requires hospitalization to prevent harm, or features psychotic delusions/hallucinations.
Bipolar II Disorder : Requires at least one hypomanic episode AND at least one major depressive episode . There has never been a lifetime manic episode.
Hypomanic Episode : Symptoms identical to mania lasting at least 4 consecutive days ; represents an unequivocal change in functioning uncharacteristic of the individual, observable by others.
Crucial Boundaries : Hypomania does not cause marked functional impairment, does not require hospitalization, and never features psychotic symptoms. The presence of psychosis automatically reclassifies the episode as Bipolar I mania.
Clinical Warning: Antidepressant Monotherapy in Bipolar Disorder
Antidepressant monotherapy is not recommended for Bipolar I depression because it can provoke mania, mixed symptoms or cycling. Do not describe Bipolar II treatment as an identical absolute rule: selected pure-depression presentations may have specialist antidepressant options, while mixed features or a switch history argue strongly against them. Assess the illness course and use the relevant specialist pathway. If antidepressants are ever utilized for refractory bipolar depression, they must always be co-prescribed with a therapeutic antimanic mood stabiliser (lithium, valproate, or an atypical antipsychotic).
Management of Acute Mania
First-Line Pharmacotherapy : Atypical antipsychotics ( olanzapine 10 to 20 mg 10\text{ to }20\text{ mg} 10 to 20 mg , quetiapine 400 to 800 mg 400\text{ to }800\text{ mg} 400 to 800 mg , risperidone 2 to 6 mg 2\text{ to }6\text{ mg} 2 to 6 mg ) or mood stabilisers ( lithium , sodium valproate ).
Severe Agitation & Psychosis : Combination therapy with an atypical antipsychotic plus a mood stabiliser (e.g., olanzapine + lithium) is superior to monotherapy. Short-term oral or intramuscular benzodiazepines (clonazepam 1 to 2 mg 1\text{ to }2\text{ mg} 1 to 2 mg or lorazepam) provide rapid behavioural de-escalation.
Primary references (checked 7 October 2026): EXTRIP lithium recommendations .